We advised WSE-listed Genomtec S.A. on a non-brokered public offering of the company’s shares carried out under an accelerated bookbuilding procedure (ABB) and a related private placement of the company’s new issue shares.
The public offering included 1,237,000 series M new issue shares and 900,000 existing WSE-listed shares of the company offered by its shareholder Leonarto Funds SCSp. The shares offered by the shareholder were previously borrowed for this purpose from other shareholders of the company. The public offering was targeted at qualified investors and selected retail investors.
As part of the private placement, the company issued 400,000 N shares, which were subscribed for by Leonarto Funds SCSp for the purpose of reinvesting the funds raised from the sale of the company’s shares in the public offering (including the funds allocated for the shareholder’s purchase of part of the M shares).
The total value of the public offering and the private placement amounted to PLN 20,296,000.
We supported the company in all legal aspects of the transaction. The scope of advisory services included, in particular, advising on the transaction structuring process, preparing and negotiating transaction documentation (including the investment agreement, loan agreements, issue documentation), advising on the implementation of the Company’s disclosure obligations, and providing legal advice on the process of dematerialization of new issue shares and admission of series M shares to trading on the regulated market of the WSE.
Bookkeeping for the shares offered in the public offering was entrusted to Brokerage INC S.A. In terms of Investor Relations, the company was also supported by cc group.
We thank Genomtec S.A. and the other advisors involved in the transaction for their fruitful cooperation and trust.
The project supervised by Krzysztof Marczuk was managed by Michal Wielinski supported by Jakub Rowicki. The project team also included Michal Dunikowski.
Genomtec S A. is a technology company operating in the field of clinical diagnostics. It was founded in 2016 in Wroclaw, Poland, with a vision of international expansion based on a unique mobile genetic diagnostics platform using a patented non-contact heating and detection system. The company, founded by a group of scientists with experience and expertise in the fields of molecular biology and microsystems and photonics, has its headquarters and laboratories in Wroclaw. Genomtec also has an office in the UK, where part of its international research and engineering team is located.
Krzysztof is a lawyer with many years of transaction and regulatory experience. He joined GESSEL in 2007 and has been a partner since 2016. He specializes in raising financing through equity issues in primary and secondary public offerings as well as private placements. He also advises on public and private bond offerings. He provides day-to-day corporate law services to publicly listed companies in all aspects of commercial law, including com...
Capital Markets | Mergers and acquisitions (M&A)
Jakub joined the GESSEL's capital market law team in 2020. His experience in the ECM sphere focuses on advising on public offerings of shares combined with IPOs as well as subsequent public offerings, including those conducted through Accelerated Book Building. He also advises on mergers and acquisitions involving public companies, including those conducted in the form of a tender offer for the sale of shares. At the same time, he specializ...
Capital Markets | Mergers and acquisitions (M&A) | Corporate law
Joined GESSEL in 2021. His main area of expertise is capital market law. Michał advises on mergers and acquisitions and corporate disputes. He handles transactions related to raising equity and debt financing through issue of financial instruments. Advises on flotations on the Warsaw Stock Exchange and the NewConnect market. Handles transactions of primary and secondary public offerings (IPOs, SPOs), accelerated book-building processes (ABB), ten...
Michał participates in work related to issues of securities via public and private offerings, including bonds. He is involved in projects related to the admission and introduction of financial instruments to trading on the regulated market. He represents clients before the Polish Financial Supervision Authority, the National Depository for Securities and the Warsaw Stock Exchange. Provides day-to-day services to public companies in the field of c...
They may interest you
GESSEL has once again been recommended in the IFLR1000 2023 international ranking
Our law firm has once again been recommended in the international IFLR1000 2023 ranking in the categories M&A, Capital markets: Equity, Capital markets: Debt. Indiv...
Transaction Sescom S.A. in the final of the 2023 Thames Valley Dealmakers Awards
The deal to sell 100% of PCB Technical Solutions Limited to Sescom SA, which we advised in the process, is a finalist in the prestigious Thames Valley Dealmakers Awards ...